Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Molecular Cell|February 20, 2018
PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsPei-I Tsai, Chin-Hsien Lin, Chung-Han Hsieh, et al.
Cell Reports|December 7, 2023
A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's diseaseVinita Bharat, Aarooran S Durairaj, Roeland Vanhauwaert, et al.
Neurology. Genetics|December 13, 2021
Confirming Pathogenicity of the F386L PSEN1 Variant in a South Asian Family With Early-Onset Alzheimer DiseaseSarah J Eger, Yann Le Guen, Raiyan R Khan, et al.
Neurology. Genetics|February 6, 2025
A 3'UTR Insertion Is a Candidate Causal Variant at the TMEM106B Locus Associated With Increased Risk for FTLD-TDPAugustine Chemparathy, Yann Le Guen, Yi Zeng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
A 3'UTR Insertion Is a Candidate Causal Variant at the TMEM106B Locus Associated with Increased Risk for FTLD-TDPAugustine Chemparathy, Yann Le Guen, Yi Zeng, et al.
Annals of Neurology|January 5, 2024
Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's DiseaseJeffery M Vance, Lindsay A Farrer, Yadong Huang, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Genome Research|March 20, 2025
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare diseaseTanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
American Journal of Human Genetics|November 12, 2021
Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease geneticsZihuai He, Yann Le Guen, Linxi Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2025
APOE *4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic AnalysesYoujie Zeng, Noah Cook, Chenyu Yang, et al.
Pageof 14